189 related articles for article (PubMed ID: 29112949)
21. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the epidermal growth factor receptor gene mutation and copy number in non-small cell lung cancer with gefitinib therapy.
Endo K; Sasaki H; Yano M; Kobayashi Y; Yukiue H; Haneda H; Suzuki E; Kawano O; Fujii Y
Oncol Rep; 2006 Sep; 16(3):533-41. PubMed ID: 16865253
[TBL] [Abstract][Full Text] [Related]
23. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
Broët P; Camilleri-Broët S; Zhang S; Alifano M; Bangarusamy D; Battistella M; Wu Y; Tuefferd M; Régnard JF; Lim E; Tan P; Miller LD
Cancer Res; 2009 Feb; 69(3):1055-62. PubMed ID: 19176396
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.
Dziadziuszko R; Witta SE; Cappuzzo F; Park S; Tanaka K; Danenberg PV; Barón AE; Crino L; Franklin WA; Bunn PA; Varella-Garcia M; Danenberg KD; Hirsch FR
Clin Cancer Res; 2006 May; 12(10):3078-84. PubMed ID: 16707605
[TBL] [Abstract][Full Text] [Related]
25. An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number.
Szutowicz-Zielińska E; Konopa K; Kowalczyk A; Suszko-Każarnowicz M; Duchnowska R; Szczęsna A; Ratajska M; Sowa A; Limon J; Biernat W; Burzykowski T; Jassem J; Dziadziuszko R
Oncotarget; 2017 Mar; 8(10):17270-17278. PubMed ID: 27924059
[TBL] [Abstract][Full Text] [Related]
26. Prognostic implications of epidermal growth factor receptor and KRAS gene mutations and epidermal growth factor receptor gene copy numbers in patients with surgically resectable non-small cell lung cancer in Taiwan.
Liu HP; Isaac Wu HD; Chang JW; Wu YC; Yang HY; Chen YT; Hsieh WY; Chen YT; Chen YR; Huang SF
J Thorac Oncol; 2010 Aug; 5(8):1175-84. PubMed ID: 20559151
[TBL] [Abstract][Full Text] [Related]
27. Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer.
Grob TJ; Hoenig T; Clauditz TS; Atanackovic D; Koenig AM; Vashist YK; Klose H; Simon R; Pantel K; Izbicki JR; Bokemeyer C; Sauter G; Wilczak W
Lung Cancer; 2013 Mar; 79(3):221-7. PubMed ID: 23238037
[TBL] [Abstract][Full Text] [Related]
28. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
[TBL] [Abstract][Full Text] [Related]
29. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer.
Dehan E; Ben-Dor A; Liao W; Lipson D; Frimer H; Rienstein S; Simansky D; Krupsky M; Yaron P; Friedman E; Rechavi G; Perlman M; Aviram-Goldring A; Izraeli S; Bittner M; Yakhini Z; Kaminski N
Lung Cancer; 2007 May; 56(2):175-84. PubMed ID: 17258348
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer.
Qiu ZW; Bi JH; Gazdar AF; Song K
Genes Chromosomes Cancer; 2017 Jul; 56(7):559-569. PubMed ID: 28379620
[TBL] [Abstract][Full Text] [Related]
31. Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial.
Douillard JY; Shepherd FA; Hirsh V; Mok T; Socinski MA; Gervais R; Liao ML; Bischoff H; Reck M; Sellers MV; Watkins CL; Speake G; Armour AA; Kim ES
J Clin Oncol; 2010 Feb; 28(5):744-52. PubMed ID: 20038723
[TBL] [Abstract][Full Text] [Related]
32. Silver-enhanced in situ hybridization for determination of EGFR copy number alterations in non-small cell lung cancer.
Wulf MA; Bode B; Zimmermann D; Rufibach K; Weder W; Moch H; Soltermann A; Tischler V
Am J Surg Pathol; 2012 Dec; 36(12):1801-8. PubMed ID: 23154768
[TBL] [Abstract][Full Text] [Related]
33. Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma.
Salomonsson A; Jönsson M; Isaksson S; Karlsson A; Jönsson P; Gaber A; Bendahl PO; Johansson L; Brunnström H; Jirström K; Borg Å; Staaf J; Planck M
Genes Chromosomes Cancer; 2013 Nov; 52(11):1088-96. PubMed ID: 24019021
[TBL] [Abstract][Full Text] [Related]
34. Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
Hirsch FR; Varella-Garcia M; McCoy J; West H; Xavier AC; Gumerlock P; Bunn PA; Franklin WA; Crowley J; Gandara DR;
J Clin Oncol; 2005 Oct; 23(28):6838-45. PubMed ID: 15998906
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of epidermal growth factor receptor and KRAS gene status between primary and corresponding metastatic tumours of non-small cell lung cancer.
Wang S; Wang Z
Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):30-9. PubMed ID: 25445553
[TBL] [Abstract][Full Text] [Related]
36. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
[TBL] [Abstract][Full Text] [Related]
37. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
38. Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer.
Huang YT; Lin X; Liu Y; Chirieac LR; McGovern R; Wain J; Heist R; Skaug V; Zienolddiny S; Haugen A; Su L; Fox EA; Wong KK; Christiani DC
Proc Natl Acad Sci U S A; 2011 Sep; 108(39):16345-50. PubMed ID: 21911369
[TBL] [Abstract][Full Text] [Related]
39. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients.
Sunpaweravong P; Thu KL; Lam WL; Mai S
J Cancer Res Clin Oncol; 2016 Apr; 142(4):749-56. PubMed ID: 26621152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]